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ScienceDirectThe metabolome describes the full complement of the tens to
hundreds of thousands of low molecular weight metabolites
present within a biological system. Identification of the
metabolome is critical for discovering the maximum amount of
biochemical knowledge from metabolomics datasets. Yet no
exhaustive experimental characterisation of any organismal
metabolome has been reported to date, dramatically
contrasting with the genome sequencing of thousands of
plants, animals and microbes. Here, we review the status of
metabolome annotation and describe advances in the
analytical methodologies being applied. In part through new
international coordination, we conclude that we are now
entering a new era of metabolome annotation.
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Introduction
Metabolomics is the multidisciplinary field of research
concerned with the study of metabolomes, the comple-
ment of naturally-occurring and exogenous (e.g. environ-
mental pollutants), low-molecular-weight (typically
<1500 Da) metabolites present within biological systems
[1]. Comprising of precursors, intermediates and products
of biochemical pathways, metabolites constitute some of
the terminal products of higher cellular processes and
collectively provide a ‘fingerprint’ of the complex inter-
play between genome and environment. From an analyt-
ical perspective, both the measurement and identification
of whole metabolomes presents a considerable challenge,Current Opinion in Chemical Biology 2017, 36:64–69 not least due to the vast structural heterogeneity of
metabolites, their large number (e.g. an estimated
200 000 structurally-distinct secondary metabolites across
the plant kingdom [2]) and their wide concentration
ranges (estimated to span 12 orders of magnitude [3]).
As a point of clarity, the formal definitions of metabolite
annotation and identification, as developed by the Chem-
ical Analysis Working Group of the Metabolomics Stan-
dards Initiative (MSI) [4], are shown in Table 1. The
categorical scoring system defines ‘identification’ as the
most rigorous (level 1) while ‘annotation’ does not require
such exhaustive analytical validation (levels 2 and 3).
Currently there are no completed lists of experimen-
tally-derived metabolites that describe the metabolome
of any model organism, not even as putative annotations.
Meaningful biological inferences may only be drawn from
metabolomics datasets where peaks can be structurally
identified as named metabolites, that is it is only when we
are empowered to move beyond discussing unidentified
peaks to rigorously identified metabolites that we can
fully engage in describing metabolic pathways and inte-
grate metabolism with other levels of biological hierarchy.
For over a decade, molecular identification has remained
the principal technical bottleneck in metabolomics [5,6].
Hence, for metabolomics to deliver its full potential in
fields from medicine to ecology, innovations in analytical
workflows are urgently required. Yet based on the liter-
ature, it is readily apparent that the core metabolomics
workflow has changed little over the past 15 years, typi-
cally comprising of sampling, measurement of metabo-
lites by mass spectrometry (MS) and/or nuclear magnetic
resonance (NMR) spectroscopy, data processing and sta-
tistical analyses, with a view to discovering peaks of
biological importance [7,8]. Those peaks are typically
searched against databases, providing limited putative
annotation. Rarely do investigators undertake the chal-
lenging and time consuming step of identifying peaks
that are not present in databases [9], using methods that
are common to natural products chemistry such as frac-
tionation, high resolution accurate mass MS, and 1D and
2D NMR for structure determination. Typically, a signif-
icant proportion of detected peaks are not annotated or
identified, dependent on the analytical platform used and
sample type. Hence it is appropriate to conclude that all
experimental metabolomics studies to date would have
generated additional biological insights were metabolite
identification a more tractable process, that in turn may
have allowed for more complete metabolome networkwww.sciencedirect.com
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Table 1
Summary of levels of confidence in metabolite ‘identification’, as defined by the Chemical Analysis Working Group of the Metabolomics
Standards Initiative [4]
Level of confidence Description Requisite analytical data
Level 1 ‘Identified metabolites’ Two orthogonal analytical techniques applied to the analysis of both the metabolite of
interest and to a chemical reference standard of suspected structural equivalence, with all
analyses performed under identical analytical conditions within the same laboratory
Examples of appropriate orthogonal data: accurate mass via MS with retention time;
accurate mass MS and fragmentation data or isotopic pattern; 2D NMR spectra;
full 1H and/or 13C NMR spectra and so on
Level 2 ‘Putatively annotated
compounds’
As for levels 3 and 4, including spectral (NMR and/or MS) similarity with public or
commercial libraries
Level 3 ‘Putatively characterised
compound classes’
As for level 4, plus spectral and/or physicochemical properties consistent with a particular
class of organic compounds
Level 4 ‘Unknown’ A discernible spectral signal (NMR, MS or other) that can be reproducibly detected and
quantifiedderivation. Metabolite identification remains a colossal
challenge and a step change is needed. Here, we review
the status of metabolome annotation, introduce the
important role of model organisms, and describe the
analytical methodologies being applied.
Can model organisms help metabolome
annotation?
A critical question is how such a transformative change
will occur in metabolomics, to address this more than
decade long problem. We believe a combination of
approaches is required, including new analytical strate-
gies, computational algorithms and database resources,
and also a concerted effort by the metabolomics commu-
nity to solve this bottleneck. This latter point has recently
been recognised with the formation, in 2015, of a scien-
tific task group of the international Metabolomics Society
to progress the characterisation of metabolomes by ini-
tially focusing on a few model organisms [10]. The value
of model organisms across biology and medicine is huge
[11]. While seemingly disparate, research into bacteria,
yeast, insects, worms, fish, rodents and plants has shown
that the core biochemical operating principles have been
conserved across all living organisms. Hence findings
derived from non-mammalian model animals, for exam-
ple can shed light on biological processes in humans
(Table 2).
The Model Organism Metabolomes (MOM) task group’s
philosophy is to leverage upon the critical mass of
research activity and knowledge that exists for model
organisms, that is to encourage the community to focus
their metabolite identification efforts on systems we
know the most about already (i.e. have species-specific
metabolite databases [12–14]), that have sequenced gen-
omes (hence can create genome-wide metabolic recon-
structions to predict metabolism; [15]), and that when the
metabolomes are successfully identified this knowledge
will be of greatest value to the community [10]. The two
primary aims of the MOM task group are to integratewww.sciencedirect.com disparate model organism-focused research groups into an
interactive community, and to share, discuss and develop
the analytical and bioinformatics strategies to progress the
identification of model organism metabolomes, resulting
in best practice documents (Figure 1). Ultimately, this
task group has set a grand challenge: to identify and map all
‘system’ metabolites onto metabolic pathways, to develop quan-
titative metabolic models for model organisms, and to relate
organism metabolic pathways within the context of evolutionary
metabolomics, that is phylometabolomics [10]. Efforts have
begun to optimise analytical methods for metabolome
identification, for example in Escherichia coli [16],
Saccharomyces cerevisiae [17] and Caenorhabditis elegans
[18], as well as to mine the literature for existing
knowledge, for example in S. cerevisiae [19]. An atlas of
tissue-specific metabolomes has also been initiated
for Drosophila melanogaster, including both polar and
lipophilic metabolites [20].
Extending our analytical strategies to
progress metabolome identification
With the ambition to more deeply characterise the com-
plete metabolomes of model organisms, what recent
developments in analytical chemistry have been applied?
Unlike for genomics, where disruptive technologies are
relatively common [21], the analytical methods used in
metabolomics have changed relatively little over the last
decade. What has occurred recently is a considerable
growth of targeted methods for studying swathes of
metabolism, likely driven by the very frustration of lim-
ited peak annotation in non-targeted metabolomics, as
discussed above. For example, a number of targeted
LC–MS/MS assays have been developed to profile from
a few tens to a couple of hundred metabolites in rice
[22,23,24] and mammalian samples [25,26]. While
benefitting from yielding metabolic data that is identified
and often quantitative, all of these studies only scrape the
surface of the thousands of metabolites estimated to com-
prise a metabolome. Hence, to an extent, this shift to
targeted assays is a distraction (except for cases whereCurrent Opinion in Chemical Biology 2017, 36:64–69
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Table 2
Species-specific metabolome databases available for the model organisms prioritised for deeper investigation by the Model Organism
Metabolomes task group [10]
Latin name Common name Database Content
Escherichia coli – E. coli Metabolome Database (ECMDB)
http://ecmdb.ca/
3755 small molecules from textbooks, scientific journals,
metabolic reconstructions and electronic databases
Saccharomyces
cerevisiae
Yeast Yeast Metabolome Database (YMDB)
http://www.ymdb.ca/
16 042 small molecules from textbooks, scientific




Nematode Small Molecule Identifiers (SMIDs)
http://smid-db.org/
ca. 180 experimentally identified metabolites
Daphnia magna Water flea None currently –
Drosophila
melanogaster
Fruit fly None currently –
Danio rerio Zebrafish None currently –
Mus musculus Mouse Mouse Multiple tissue Metabolome DataBase
(MMMDB) http://mmmdb.iab.keio.ac.jp/










Barrel medic MedicCyc 2.0 http://mediccyc.noble.org/ Metabolic pathway reconstruction, contains
>400 pathways with related genes, enzymes and
metabolites
Oryza sativa Rice OryzaCyc 4.0
http://www.plantcyc.org/databases/oryzacyc/4.0






Metabolic pathway reconstruction, contains
2550 compoundsthe targets are already known) from solving the real chal-
lenge of metabolite identification and understanding biol-
ogy in greater detail utilising non-targeted metabolomics.
So what is the current status of non-targeted metabolo-
mics for fully characterising metabolomes? Both gasFigure 1
Schematic workflow for the deep experimental characterisation of the meta
access metabolome databases would greatly accelerate the study of metab
Current Opinion in Chemical Biology 2017, 36:64–69 chromatography (GC) and liquid chromatography (LC)
methods continue to be developed, including multi-
dimensional chromatography and the application of mul-
tiple columns for the separation of different classes of
metabolites. For example, a ‘broad spectrum’ GC–MS
method has been developed to measure non-volatileExtraction
e.g. liquid-liquid, SPE
Separation






e.g. 1D & 2D NMR, MS, MSn
Current Opinion in Chemical Biology
bolomes of model organisms. The creation of such knowledge in open-
olism in an evolutionary context, that is phylometabolomics.
www.sciencedirect.com
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detected of which the authors identified only 45. Utilising
a comprehensive GCxGC approach, coupled with head-
space solid phase microextraction (HS SPME) and a time
of flight (ToF) MS, Alves et al. reported the identification
of 257 volatile metabolites from S. cerevisiae distributed
over more than a dozen chemical families [28]. For a
recent review of advanced multi-dimensional separations
in mass spectrometry, see Ref. [29]. The inherent
requirements of GC–MS for the thermal stability and
volatility of the analytes, or derivatives thereof, means
that, alone, this technique is unable to facilitate compre-
hensive metabolome annotation. Instead, the majority of
non-targeted metabolomics studies continue to employ
LC, and there is an increasing trend towards the applica-
tion of several column types in a given study; for example
Tufi et al. not only used two LC columns (C18 and HILIC)
but also GC–MS to study a freshwater snail Lymnaea
stagnalis [30]. This more comprehensive analytical
approach was applied specifically to obtain a broader
picture of the hydrophilic and lipophilic metabolome.
The application of multiple analytical platforms, as
applied to L. stagnalis [30] is an emerging trend in
metabolomics. Geier et al. [31] applied three different
platforms to analyse C. elegans, including 1D 1H NMR
spectroscopy, GC/MS and UPLC–MS. The deeper inte-
gration of NMR and MS data in automated metabolite
identification pipelines is an emerging topic [32]. An even
broader range of metabolites were measured in 31 varie-
ties of rice using HS SPME GC–MS, primary polar
metabolites by GC-ToF-MS, both polar and semi-polar
compounds by 1H NMR and direct infusion MS, and
multi-elemental analysis using ICP-MS [33]. While
more time intensive and costly, deeper characterisation
of organismal metabolomes currently requires such a
multi-platform strategy. Fortunately, as long as the met-
abolic knowledge is captured in relevant open access
databases, such as MetaboLights [34], then this strategy
only needs to be conducted once. A related project to
deeply annotate the metabolome of the NIH model
species Daphnia magna (waterflea) is underway in the
primary authors’ laboratory, applying multiple extraction
methods, LC–MS/MS and MSn methods, GC-Orbitrap
MS, and 1D and 2D NMR spectroscopy. Progress has also
been reported in the integration of several platforms to
enable metabolite identification by UHPLC–SPE–
NMR–MS [35]. In addition, approaches such as ion
mobility mass spectrometry [36] and ultrahigh resolution
mass spectrometry [37] hold considerable promise for
contributing to metabolome annotation projects.
Another methodology that has considerable potential for
aiding metabolite identification is stable isotope labelling,
for example to probe the sulfur metabolome of Arabidop-
sis [38,39]. Isotopic ratio outlier analysis (IROA) is another
isotope labelling technology that is designed to generatewww.sciencedirect.com specific 13C isotopic patterns in metabolites for both high
resolution LC–MS and GC–MS [17,40–43]. Unlike
other stable isotope labelling methods, rather than
utilising natural abundance and 98–99% enrichment for
the control and experimental populations, respectively
[44–48], IROA uses an enrichment level of 95% and 5%
13C. This leads to more observable isotopic peaks in the
mass spectra in predictable and diagnostic patterns.
Recent studies have demonstrated the promise of IROA
for metabolic phenotyping in model organisms, including
for prototrophic S. cerevisiae [17,49] and C. elegans [43];
the latter was grown in liquid culture with 13C-labeled E.
coli that was first grown in M9 minimal media on either
95% or 5% 13C glucose, creating labelled C. elegans. These
95% 13C and 5% 13C glucose labelling experiments, when
extracted and combined, show distinctive IROA patterns:
12C-derived molecules, 13C-derived molecules, artifacts
(lack IROA patterns) and derivatives of exogenously
applied compounds. Only metabolites of biological origin
will have mirrored 12C and 13C metabolite peaks at the
same retention time. Furthermore, the abundance of the
heavy isotopologues in the 5% 13C samples (M + 1, M + 2,
etc. the 12C envelope) or light isotopologues in the 95%
13C samples (M  1, M  2, etc. the 13C envelope), fol-
lows the binomial distribution for 13C in metabolite
products based on the initial substrate enrichment.
The mass difference between the 12C monoisotopic peak
and the 13C monoisotopic peak indicates the number of
carbons in the metabolite. Uniquely, the accurate mass
IROA–GC/MS protocol developed, using both chemical
ionization (CI) and electron ionization (EI), extends the
information acquired from the isotopic peak patterns for
molecular formulae generation. The process has been
formulated as an algorithm, in which the numbers of
carbons, methoximations and silylations are used as
search constraints, and an accurate mass CI IROA library
with retention times based on the Fiehn protocol has
been published [17]. The combination of CI and EI
IROA protocols affords a metabolite identification pro-
cedure that can identify co-eluting metabolites [17]. In
summary, non-targeted stable isotope metabolite profil-
ing using IROA reduces the complexity for global stable
isotope metabolite identification [50], and can extend
metabolome analysis by identifying ‘known unknowns’
with an IROA mirror pattern, and generating the number
of carbons in the unknown metabolite.
Conclusions
The hugely beneficial impact of the Human Genome
Project on 21st century science is undeniable [51,52]. No
such large-scale experimental characterisations of organ-
ism metabolomes have been reported and many of the
studies published to date describe only a fraction of the
estimated size of a metabolome. That said, efforts are now
underway from text mining to novel experimental
approaches that offer to accelerate this process, and
coordination of some of these activities is being achievedCurrent Opinion in Chemical Biology 2017, 36:64–69
68 Omicsthrough the Metabolomics Society’s task group. Activity
in metabolome identification is therefore expected to
increase over the next couple of years with significant
returns on this investment within 5–10 years. Looking
further ahead, challenges will include developing analyt-
ical strategies to quantify several thousand known metab-
olites (simultaneously) as well as the spatial localisation of
these compounds, for example using MS imaging [53,54].
Ultimately, a better understanding of the parts list is
going to facilitate growth of several fields, including
phylometabolomics, the study of organism metabolic
pathways in the context of evolution.
Acknowledgements
This work was in part supported by the UK Natural Environment Research
Council (NE/J017442/1), Thermo Fisher Scientific (CASE award) and by an
Einstein-Mount Sinai Diabetes Research Center Grant (P60DK020541).
References and recommended reading
Papers of particular interest, published within the period of review,
have been highlighted as:
 of special interest
 of outstanding interest
1. Oliver SG, Winson MK, Kell DB, Baganz F: Systematic functional
analysis of the yeast genome. Trends Biotechnol 1998,
16:373-378.
2. Hartmann T: From waste products to ecochemicals: fifty years
research of plant secondary metabolism. Phytochemistry 2007,
68:2831-2846.
3. Lei ZT, Huhman DV, Sumner LW: Mass spectrometry strategies
in metabolomics. J Biol Chem 2011, 286:25435-25442.
4. Sumner LW, Amberg A, Barrett D, Beale MH, Beger R, Daykin CA,
Fan TWM, Fiehn O, Goodacre R, Griffin JL et al.: Proposed
minimum reporting standards for chemical analysis.
Metabolomics 2007, 3:211-221.
5. Wishart DS: Advances in metabolite identification. Bioanalysis
2011, 3:1769-1782.
6. Dunn WB, Erban A, Weber RJM, Creek DJ, Brown M, Breitling R,
Hankemeier T, Goodacre R, Neumann S, Kopka J et al.: Mass
appeal: metabolite identification in mass spectrometry-
focused untargeted metabolomics. Metabolomics 2013,
9:S44-S66.
7. Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S,
Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN et al.:
Procedures for large-scale metabolic profiling of serum and
plasma using gas chromatography and liquid chromatography
coupled to mass spectrometry. Nat Protoc 2011, 6:1060-1083.
8. Southam Andrew D, Weber Ralf JM, Engel Jasper, Jones Martin R,
Viant Mark R: A complete workflow for high-resolution
spectral-stitching nanoelectrospray direct-infusion mass-
spectrometry-based metabolomics and lipidomics. Nature
Protocols 2016, 12:255-273 http://dx.doi.org/10.1038/
nprot.2016.156 Published online 12 January 2017.
9. Gillard J, Frenkel J, Devos V, Sabbe K, Paul C, Rempt M, Inze D,
Pohnert G, Vuylsteke M, Vyverman W: Metabolomics enables
the structure elucidation of a diatom sex pheromone.
Angew Chem Int Ed 2013, 52:854-857.
10.

Edison AS, Hall RD, Junot C, Karp PD, Kurland IJ, Mistrik R,
Reed LK, Saito K, Salek RM, Steinbeck C et al.: The time is right
to focus on model organism metabolomes. Metabolites 2016, 6.
Describes the launch of the first internationally coordinated action to
accelerate research into the deep characterisation of model organism
metabolomes. A team of scientists have laid down the challenge “to
identify and map all ‘system’ metabolites onto metabolic pathways, to
develop quantitative metabolic models for model organisms, and to relateCurrent Opinion in Chemical Biology 2017, 36:64–69 organism metabolic pathways within the context of evolutionary
metabolomics.”
11. Fontana L, Partridge L: Promoting health and longevity through
diet: from model organisms to humans. Cell 2015, 161:106-118.
12. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D,
Jewell K, Arndt D, Sawhney S et al.: HMDB: the human
metabolome database. Nucleic Acids Res 2007, 35:D521-D526.
13. Jewison T, Knox C, Neveu V, Djoumbou Y, Guo AC, Lee J, Liu P,
Mandal R, Krishnamurthy R, Sinelnikov I et al.: YMDB: the yeast
metabolome database. Nucleic Acids Res 2012, 40:D815-D820.
14. Guo AC, Jewison T, Wilson M, Liu YF, Knox C, Djoumbou Y, Lo P,
Mandal R, Krishnamurthy R, Wishart DS: ECMDB: the E. coli
metabolome database. Nucleic Acids Res 2013, 41:D625-D630.
15. Kim T, Dreher K, Nilo-Poyanco R, Lee I, Fiehn O, Lange BM,
Nikolau BJ, Sumner L, Welti R, Wurtele ES et al.: Patterns of
metabolite changes identified from large-scale gene
perturbations in Arabidopsis using a genome-scale metabolic
network. Plant Physiol 2015, 167:U1685-U1890.
16. Shen Y, Fatemeh T, Tang LH, Cai ZW: Quantitative metabolic
network profiling of Escherichia coli: an overview of analytical
methods for measurement of intracellular metabolites. TRAC
Trends Anal Chem 2016, 75:141-150.
17.

Qiu Y, Moir R, Willis I, Beecher C, Tsai YH, Garrett TJ, Yost RA,
Kurland IJ: Isotopic ratio outlier analysis of the S. cerevisiae
metabolome using accurate mass gas chromatography/time-
of-flight mass spectrometry: a new method for discovery.
Anal Chem 2016, 88:2747-2754.
First report using IROA technology in combination with accurate mass
GC/TOF-MS, used to examine theS. cerevisiae metabolome. An accurate
mass CI IROA library containing 126 metabolites with retention times
based on the Fiehn protocol was established. The combination of CI and
EI IROA protocols identifies co-eluting metabolites and differentiates
metabolite spectra from artifacts, and “known unknown” metabolites
were easily separated, with the number of carbons identified from the
IROA patterns.
18. Stupp GS, Clendinen CS, Ajredini R, Szewc MA, Garret T,
Menger RF, Yost RA, Beecher C, Edison AS: Isotopic ratio outlier
analysis global metabolomics of Caenorhabditis elegans.
Anal Chem 2013, 85:11858-11865.
19. Nobata C, Dobson PD, Iqbal SA, Mendes P, Tsujii J, Kell DB,
Ananiadou S: Mining metabolites: extracting the yeast
metabolome from the literature. Metabolomics 2011, 7:94-101.
20. Chintapalli VR, Al Bratty M, Korzekwa D, Watson DG, Dow JAT:
Mapping an atlas of tissue-specific Drosophila melanogaster
metabolomes by high resolution mass spectrometry.
PLoS One 2013, 8.
21. Mikheyev AS, Tin MMY: A first look at the Oxford Nanopore
MinION sequencer. Mol Ecol Resour 2014, 14:1097-1102.
22. Cao ZY, Sun LH, Mou RX, Zhang LP, Lin XY, Zhu ZW, Chen MX:
Profiling of phytohormones and their major metabolites in rice
using binary solid-phase extraction and liquid
chromatography-triple quadrupole mass spectrometry.
J Chromatogr A 2016, 1451:67-74.
23. Hu CY, Tohge T, Chan SA, Song Y, Rao J, Cui B, Lin H, Wang L,
Fernie AR, Zhang DB et al.: Identification of conserved and
diverse metabolic shifts during rice grain development.
Sci Rep 2016, 6.
24.

Schafer M, Brutting C, Baldwin IT, Kallenbach M: High-
throughput quantification of more than 100 primary- and
secondary-metabolites, and phytohormones by a single solid-
phase extraction based sample preparation with analysis by
UHPLC–HESI–MS/MS. Plant Methods 2016, 12.
Excellent demonstration of the quantitatitive capabilities of targeted
metabolite analysis, here assaying more than 100 primary and secondary
metabolites simultaneously following a single extraction of plant material.
Such an approach is highly recommended when the metabolite ‘targets’
are already known, and hence non-targeted metabolomics is not
required.
25. Chen JH, Hou W, Han B, Liu GH, Gong J, Li YM, Zhong DM,
Liao QF, Xie ZY: Target-based metabolomics for the
quantitative measurement of 37 pathway metabolites in ratwww.sciencedirect.com
How close are we to complete annotation of metabolomes? Viant et al. 69brain and serum using hydrophilic interaction ultra-
high-performance liquid chromatography–tandem mass
spectrometry. Anal Bioanal Chem 2016, 408:2527-2542.
26. Jain M, Nilsson R, Sharma S, Madhusudhan N, Kitami T, Souza AL,
Kafri R, Kirschner MW, Clish CB, Mootha VK: Metabolite profiling
identifies a key role for glycine in rapid cancer cell
proliferation. Science 2012, 336:1040-1044.
27. Khakimov B, Mongi RJ, Sorensen KM, Ndabikunze BK, Chove BE,
Engelsen SB: A comprehensive and comparative GC–MS
metabolomics study of non-volatiles in Tanzanian grown
mango, pineapple, jackfruit, baobab and tamarind fruits.
Food Chem 2016, 213:691-699.
28. Alves Z, Melo A, Figueiredo AR, Coimbra MA, Gomes AC,
Rocha SM: Exploring the Saccharomyces cerevisiae volatile
metabolome: indigenous versus commercial strains.
PLoS One 2015, 10.
29. May JC, McLean JA: Advanced multidimensional separations
in mass spectrometry: navigating the big data deluge. In




Tufi S, Lamoree MH, De Boer J, Leonards PEG: Cross-platform
metabolic profiling: application to the aquatic model organism
Lymnaea stagnalis. Anal Bioanal Chem 2015, 407:1901-1912.
Good example of the application of several separation technologies– both
GC and LC – with the latter using two different column chemistries
(C18 and HILIC). This approach was used to increased the breadth of
experimental measurement of the snail metabolome.
31.

Geier FM, Want EJ, Leroi AM, Bundy JG: Cross-platform
comparison of Caenorhabditis elegans tissue extraction
strategies for comprehensive metabolome coverage.
Anal Chem 2011, 83:3730-3736.
Good example of the application of multiple analytical platforms to enable
a deeper characterisation of this important model organism’s metabo-
lome. Multiple tissue extraction strategies were examined and an 80%
methanol solution was determined to be the best.
32. Bingol K, Bruschweiler R: Knowns and unknowns in
metabolomics identified by multidimensional NMR and hybrid
MS/NMR methods. Curr Opin Biotechnol 2016, 43:17-24.
33.

Mumm R, Hageman JA, Calingacion MN, de Vos RCH, Jonker HH,
Erban A, Kopka J, Hansen TH, Laursen KH, Schjoerring JK et al.:
Multi-platform metabolomics analyses of a broad collection
of fragrant and non-fragrant rice varieties reveals the
high complexity of grain quality characteristics. Metabolomics
2016, 12.
An exemplary paper, demonstrating through hierarchical cluster analysis,
both the complementarity and distinct merits of multiple analytical plat-
forms in the study of rice variant metabolome constituents. Importantly,
data is interrogated in a way that aligns well with the vision of the MOM
task group, i.e. phylometabolomic comparisons, for a crop species of
fundamental societal importance.
34. Haug K, Salek RM, Conesa P, Hastings J, de Matos P, Rijnbeek M,
Mahendraker T, Williams M, Neumann S, Rocca-Serra P et al.:
MetaboLights—an open-access general-purpose repository
for metabolomics studies and associated meta-data. Nucleic
Acids Res 2013, 41:D781-D786.
35. Gu WY, Li N, Leung ELH, Zhou H, Yao XJ, Liu L, Wu JL:
Rapid identification of new minor chemical constituents from
Smilacis Glabrae Rhizoma by combined use of UHPLC–Q-
TOF-MS, preparative HPLC and UHPLC–SPE–NMR–MS
techniques. Phytochem Anal 2015, 26:428-435.
36. May JC, Branum RLG, McLean JA: Targeting the untargeted
in molecular phenomics with structurally-selective ion
mobility-mass spectrometry. Curr Opin Biotechnol 2016,
39:192-197.
37. Romano S, Dittmar T, Bondarev V, Weber RJM, Viant MR,
Schulz-Vogt HN: Exo-metabolome of Pseudovibrio sp.
FO-BEG1 analyzed by ultra-high resolution mass
spectrometry and the effect of phosphate limitation.
PLoS One 2014, 9.www.sciencedirect.com 38. Glaser K, Kanawati B, Kubo T, Schmitt-Kopplin P, Grill E:
Exploring the Arabidopsis sulfur metabolome. Plant J 2014,
77:31-45.
39. Nakabayashi R, Tsugawa H, Mori T, Saito K: Automation of
chemical assignment for identifying molecular formula of
S-containing metabolites by combining metabolomics and
chemoinformatics with 34S labeling. Metabolomics 2016,
12:168 http://dx.doi.org/10.1007/s11306-016-1115-5.
40. Clendinen CS, Stupp GS, Ajredini R, Lee-McMullen B, Beecher C,
Edison AS: An overview of methods using 13C for improved
compound identification in metabolomics and natural
products. Front Plant Sci 2015, 6:611.
41. de Jong FA, Beecher C: Addressing the current bottlenecks of
metabolomics: isotopic ratio outlier analysis, an isotopic-
labeling technique for accurate biochemical profiling.
Bioanalysis 2012, 4:2303-2314.
42. Edison AS, Clendinen CS, Ajredini R, Beecher C, Ponce FV,
Stupp GS: Metabolomics and natural-products strategies to
study chemical ecology in nematodes. Integr Comp Biol 2015,
55:478-485.
43. Stupp GS, Clendinen CS, Ajredini R, Szewc MA, Garrett T,
Menger RF, Yost RA, Beecher C, Edison AS: Isotopic ratio outlier
analysis global metabolomics of Caenorhabditis elegans.
Anal Chem 2013, 85:11858-11865.
44. Giavalisco P, Kohl K, Hummel J, Seiwert B, Willmitzer L:
13C isotope-labeled metabolomes allowing for improved
compound annotation and relative quantification in liquid
chromatography–mass spectrometry-based metabolomic
research. Anal Chem 2009, 81:6546-6551.
45. Wu L, Mashego MR, van Dam JC, Proell AM, Vinke JL, Ras C, van
Winden WA, van Gulik WM, Heijnen JJ: Quantitative analysis of
the microbial metabolome by isotope dilution mass
spectrometry using uniformly 13C-labeled cell extracts as
internal standards. Anal Biochem 2005, 336:164-171.
46. Bennett BD, Yuan J, Kimball EH, Rabinowitz JD: Absolute
quantitation of intracellular metabolite concentrations by an
isotope ratio-based approach. Nat Protoc 2008, 3:1299-1311.
47. Weindl D, Wegner A, Jager C, Hiller K: Isotopologue ratio
normalization for non-targeted metabolomics. J Chromatogr A
2015, 1389:112-119.
48. Blank LM, Desphande RR, Schmid A, Hayen H: Analysis of
carbon and nitrogen co-metabolism in yeast by ultrahigh-
resolution mass spectrometry applying 13C- and 15N-labeled
substrates simultaneously. Anal Bioanal Chem 2012, 403:2291-
2305.
49. VanderSluis B, Hess DC, Pesyna C, Krumholz EW, Syed T,
Szappanos B, Nislow C, Papp B, Troyanskaya OG, Myers CL et al.:
Broad metabolic sensitivity profiling of a prototrophic yeast
deletion collection. Genome Biol 2014, 15:R64.
50. Weindl D, Wegner A, Hiller K: Metabolome-wide analysis of
stable isotope labeling—is it worth the effort? Front Physiol
2015, 6:344.
51. Lander ES, Int Human Genome Sequencing C, Linton LM, Birren B,
Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M
et al.: Initial sequencing and analysis of the human genome.
Nature 2001, 409:860-921.
52. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG,
Smith HO, Yandell M, Evans CA, Holt RA et al.: The sequence of
the human genome. Science 2001, 291:1304-1351.
53. Boughton BA, Thinagaran D, Sarabia D, Bacic A, Roessner U:
Mass spectrometry imaging for plant biology: a review.
Phytochem Rev 2016, 15:445-488.
54. Palmer A, Trede D, Alexandrov T: Metabolomics2016, 12:107
http://dx.doi.org/10.1007/s11306-016-1047-0.Current Opinion in Chemical Biology 2017, 36:64–69
